Tenet Healthcare price target raised to $60 from $55 at Truist

Truist analyst David MacDonald raised the firm’s price target on Tenet Healthcare to $60 from $55 and keeps a Buy rating on the shares as part of a broader research note on Hospitals. The analyst notes that his Q4 hospital survey suggests "decent utilization" with sequential improvement across care settings and a labor environment that is showing signs of improvement despite the "difficult backdrop".